WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3301 Infant (under 12 months) mortality rate: 922
GDP / capita (US$): 6061 Child (under 5 years) mortality rate: 1302

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 4'900  4'804  4'711  4'620  4'531  3'726  2'938  2'274 
Births 164  163  161  159  157  146  121  97 
Surviving infants 150  148  146  144  142  129  108  86 
Pop. less than 5 years 708  697  684  673  663  605  502  385 
Pop. less than 15 years 1'914  1'892  1'870  1'847  1'824  1'570  1'268  961 
Female 15-49 years 1'225  1'193  1'163  1'133  1'105  877  666  519 

Number of reported cases

(Click for retrospective incidence data for Central African Republic (the))
Diphtheria
ChartChart
  35 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  150  210  596  141  679  3'207  1'275  8'280 
Mumps
ChartChart
 
Pertussis
ChartChart
  379  241  124  124  100  46  4'340 
Polio*
ChartChart
  28  21 
Rubella
ChartChart
  354  507  31  11  15 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  96  24  68  65  49  37  32 
Tetanus (total)**
ChartChart
  96  24  68  74  49  37  34  217 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Central African Republic (the))
Vaccine year result method % card seen                                                
BCG 2011  74  EPI   50  56  50  39  61  69  47  93  17 
DTP1 2009  65  MICS   32  69  72  44  78  84  46 
DTP3 2011  47  EPI   50  47  45  28  59  64  29  61  13 
DTP4         
IPV1          42 
HepB_BD         
HepB3 2011  47  EPI   50  47  45  28  58  64 
Hib3 2011  47  EPI   50  47  45  28  58  64 
JapEnc         
MCV1          50  59  29  65  80  34  67  12 
MCV2         
PCV1          62  63  32  75  38 
PCV3          42  38  20  52 
Pol3 2011  71  EPI   50  46  50  28  55  67  31  57  13 
Rota1         
RotaC         
Rubella1         
TT2plus 2009  53  MICS   32  52  53  33  76  81  20  65 
PAB         
VAD1          12  40  13  19 
YFV 2011  48  EPI   50  45  44  29  64  79  19 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Central African Republic (the))
BCG
ChartChart
  74  74  37  74  74  66  96  17 
DTP1
ChartChart
  69  69  35  69  69  60  95  35 
DTP3
ChartChart
  47  47  23  47  47  37  82  13 
HepB3
ChartChart
  47  47  23  47  47 
HepB_BD
ChartChart
 
Hib3
ChartChart
  47  47  23  47  47 
IPV1
ChartChart
 
MCV1
ChartChart
  49  49  25  49  49  36  82  12 
MCV2
ChartChart
 
PAB
ChartChart
  60  60  66  66  80  36  69 
PCV3
ChartChart
  47  47  23  47 
Pol3
ChartChart
  47  47  23  47  47  38  82  13 
RCV1
ChartChart
 
RotaC
ChartChart
 
YFV
ChartChart
  48  48  24  48  48  36 

Number of districts in the country 30  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
94 
   
/
|
|
\
Greater or equal to 90% 7
From 80 to 89% 0
From 50 to 79% 40
Less than 50% 53
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes
Measles 9 months; Yes
MenA Yes Introduction in April 2017
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Td 1st contact; +1, +6 months; +1, +1 years; Yes Pregnant women
VitaminA 6, 12 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2017  2011-2015  2011-2015  2011-2015  2011-2015  2008 - 2012  2008-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 30  22  24  24  24  24  24 

System performance

Total Nº districts in country number 30  30  24  24  24  24  24 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 10  13  33  13  38 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 20  38  13 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  No  No   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  Yes  Yes  Yes  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 18  1'783  66 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No    No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.